Results 191 to 200 of about 308,964 (330)

The efficacy and safety of long-term antihypertensive therapy with nifedipine.

, 1986
Keiji Ueda, Iwao Kuwajima, Mototaka Murakami, Hiromi Yoshida   +3 more
openalex   +2 more sources

Long‐term remission in gout: Challenges and future opportunities

Rheumatology &Autoimmunity, EarlyView.
Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley   +1 more source

The Effect of Chronotherapy on Clinical Outcomes in Hypertensive Patients: A Systematic Review and Meta-Analysis Comparing Bedtime Versus Morning Dosing of Antihypertensive Drugs. [PDF]

Health Sci Rep
Azami P, Hosseinpour A, Zandi E, Rajabi F, Mirhosseini A, Farhangdoust S, Attar A.   +6 more
europepmc   +1 more source

Antihypertensive effect of tetrandrine derivative in rats.

, 1995
Matao Sakanashi
openalex   +2 more sources

Hepatic fibrosis in patients diagnosed with rheumatoid arthritis and psoriatic arthritis receiving methotrexate: A cross‐sectional analysis using transient elastography

Rheumatology &Autoimmunity, EarlyView.
Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Kanon Jatuworapruk   +3 more
wiley   +1 more source

Maximizing blood pressure lowering effects: a review of drug class comparisons and rationale for combination approaches. [PDF]

Front Cardiovasc Med
Yang Y, Wan F, Xu J, Mei Deng H, Pan P.
europepmc   +1 more source

Antihypertensive effects of NZ-105, a novel dihydropyrldine calcium antagonist, in conscious renal hypertensive dogs

, 1990
Norimitsu Kawamura, Toshinori Sakai, Yukinori Masuda, Toshihisa Oda, Misako Asada, Sakuya Tanaka, Hitoshi Kato   +6 more
openalex   +1 more source

Obstructive sleep apnea and cardiovascular disease in individuals with metabolic dysfunction‐associated fatty liver disease: A prospective cohort study

Sleep Research, EarlyView.
Abstract Objective To assess the association between obstructive sleep apnea (OSA) risk levels and major cardiovascular disease (CVD) subtypes in individuals with metabolic dysfunction‐associated fatty liver disease (MAFLD). Methods This cohort study included 128,022 MAFLD participants from the UK Biobank without CVD at baseline.
Haizhen Chen, Ying Zheng, Hanzhang Wu, Ningjian Wang, Xiao Tan   +4 more
wiley   +1 more source

Effects of at-risk drinking on central hemodynamics and aortic stiffness in midlife adults. [PDF]

Physiol Rep
Chang KY, Liu Z, Nirmal H, Hibner BA, Nashawati M, Kolade JO, Kim Y, Brothers RM, Phillips SA, Hwang CL.   +9 more
europepmc   +1 more source

Effects of cilnidipine, an antihypertensive drug, on the cardiac L-type and sympathetic N-type Ca2+ channel currents

, 1998
Hirohisa Uchida, Hisayuki Uneyama, Ryota Yoshimoto, Kazuhide Inoue, Norio Akaike   +4 more
openalex   +1 more source